S&P 500 7,498.96 -0.14% NASDAQ 25,690.90 -0.57% DOW 52,218.58 -0.01% R2K 2,959.94 -0.92% VIX 16.64 -2.40% US 10Y 4.66 +0.63% DXY 101.13 -0.05% GOLD 4,135.00 +1.57% CRUDE 86.48 +1.85% BITCOIN 65,954.64 -0.83%
Next Bullish Trade
Sign in
BIIB

Biogen Inc. NMS · BIIB

$197.74 -5.42 (-2.67%)
Pullback · -0.54σ
+ Compare Open in Sniper

Valuation

Market cap $29.2B
P/E (ttm) 21.3
Forward P/E 12.0
Beta (5y) 0.16
Shares out 147.6M
Div yield —

Profitability & returns

ROE 7.7%
Net margin 13.8%
FCF margin 19.4%
Debt / equity 0.35

Trading information

Last price $197.74
Day range $197.40 – $204.30
52-wk range $168.64 – $219.72
Avg volume 1.3M
RSI (2) 25.4
Trend zone Pullback
52-week range · today's price
$168.64$219.72

Company

Sector Healthcare
Industry Drug Manufacturers - General
Exchange NMS
Next earnings 2026-07-29

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etan…